Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2021

Net Loss Per Share

Schedule of reconciliation of net loss

	For the Year Ended
	December 31,
	2021		2020
Net loss	$	(35,400,807)	$	(26,381,389)
Net loss - Non-controlling interest		(329,339)		(331,652)
Net loss attributable to Heat Biologics, Inc.	$	(35,071,468)	$	(26,049,737)
Weighted-average common shares outstanding, basic and diluted		24,913,942		15,982,568
Net loss per share, basic and diluted	$	(1.41)	$	(1.63)

Schedule of potentially dilutive securities

	2021	2020
Outstanding stock options	2,954,315	1,480,139
Restricted stock subject to forfeiture and restricted stock units	370,170	241,828
Outstanding common stock warrants	747,383	758,939